Menopausal Hair Supplement

A six-month randomized, double-blind, placebo-controlled trial in women ages 40 to 65 found that a menopause-targeted supplement increased terminal hairs by approximately 10% at day 180. Shedding decreased by about 30% after six months in the active supplement group. Over 80% to 90% of women reportedly preferred taking an oral supplement over applying a topical product to the scalp. Vellus hairs declined by about 3% in the placebo group, interpreted as evidence that hair loss progression continues without intervention. Saw palmetto was included as a DHT blocker to address the relative androgen increase that occurs when estrogen and progesterone fall during menopause. Astaxanthin was added as an antioxidant described as approximately 600 times more powerful than vitamin C, targeting oxidative stress and aging-related follicle changes. Ashwagandha was included as a stress adaptogen to help the body properly regulate its stress response and avoid remaining in a stress state for too long. Maca was included for its alkaloids that act on the hypothalamic-pituitary-gonadal axis and may help soften the abrupt decline in estrogen production during menopause.